Aytu BioPharma (AYTU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist

1.5082
+0.0182+1.22%

Close Nov 21 16:00 ET

9.27MMarket Cap-985P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations
Yahoo FinanceNov 16 08:31 ET
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET
Maxim Group Maintains Aytu BioPharma(AYTU.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsNov 15 16:31 ET · Ratings
Aytu BioPharma Shares Are Trading Lower. The Company Reported Q1 Financial Results.
BenzingaNov 14 15:40 ET
Express News | Aytu BioPharma Shares Are Trading Lower. The Company Reported Q1 Financial Results
BenzingaNov 14 15:40 ET
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript
Earnings Call TranscriptsNov 13 19:25 ET

Comments

Jaguar8

Oct 1 07:11

NEWS

$Aytu BioPharma (AYTU.US)$
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada
DENVER, CO / ACCESSWIRE / October 1, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing ...